Portal de Periódicos da CAPES

Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head

2007; Oxford University Press; Volume: 157; Issue: 1 Linguagem: Inglês

10.1111/j.1365-2133.2007.07942.x

1365-2133

Agustı́n Alomar, Jens Bichel, Scott McRae,

Cutaneous lymphoproliferative disorders research

Journal Article Vehicle‐controlled, randomized, double‐blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head Get access A. Alomar, A. Alomar Hospital de la Santa Creu i Sant Pau, Dermatology Service, Avda. San Antonio María Claret, 167, Barcelona, Spain*3M Medica, D‐41460 Neuss, Germany †3M Pharmaceuticals, St Paul, MN 55144, U.S.A. Correspondence: Augustín Alomar. E‐mail: aalomar@hsp.santpau.es Search for other works by this author on: Oxford Academic Google Scholar J. Bichel, J. Bichel Hospital de la Santa Creu i Sant Pau, Dermatology Service, Avda. San Antonio María Claret, 167, Barcelona, Spain*3M Medica, D‐41460 Neuss, Germany †3M Pharmaceuticals, St Paul, MN 55144, U.S.A. Search for other works by this author on: Oxford Academic Google Scholar S. McRae S. McRae Hospital de la Santa Creu i Sant Pau, Dermatology Service, Avda. San Antonio María Claret, 167, Barcelona, Spain*3M Medica, D‐41460 Neuss, Germany †3M Pharmaceuticals, St Paul, MN 55144, U.S.A. Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 157, Issue 1, 1 July 2007, Pages 133–141, https://doi.org/10.1111/j.1365-2133.2007.07942.x Published: 01 July 2007